Antonio Musolino

Dr. Antonio Musolino

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
MRMarco Roversi
Marco Roversi
FPFrancesca Pignatelli
Francesca Pignatelli
GMGiacomo de Marco
Giacomo de Marco
OVOscar Vazquez
Oscar Vazquez
DCDimitri Ceroni
Dimitri Ceroni
OGon behalf of the Osteomyelitis Collaborative Study Group
on behalf of the Osteomyelitis Collaborative Study Group
This study aimed to identify key differences between K. kingae infections and those caused by S. aureus or other pathogens. Differentiating these infections is crucial due to their nonspecific clinical presentations and overlapping laboratory and radiological findings, particularly when isolates are unavailable. We retrospectively analyzed data from 702 pediatric patients with bone and joint infections from 2010 to 2023 across two hospitals. The most common diagnoses were osteomyelitis (35.3%) and arthritis (29.6%), with fever present in 46.0% of cases. Pathogen identification showed K. kingae (40.9%) and S. aureus (36.5%) as the most frequent. Patients with K. kingae were significantly younger (median age 1.5 years) than those with S. aureus (10.4 years) or other pathogens (6.8 years) (p < 0.001). Fever was more common in S. aureus (64.3%) and other pathogens (57.5%) than in K. kingae (26.4%) (p < 0.001). CRP levels were lower in K. kingae infections (median 1.5 mg/dl) compared to S. aureus (6.1 mg/dl) and other pathogens (5.0 mg/dl) (p < 0.001). K. kingae infections were predominantly treated with penicillin–clavulanate and had shorter treatment durations and lower sequelae rates (2.3%) compared to other pathogens (19.0%). These findings emphasize K. kingae’s distinct clinical profile and milder course compared to S. aureus and other pathogens.

2 February 2024 in Children
Verified
Journal Article
Open access
PDF file
SCSebastian Cristaldi
Sebastian Cristaldi
ABAlessandra Boni
Alessandra Boni
VFValentina Ferro
Valentina Ferro
AMAntonio Musolino
Antonio Musolino
NVNicoletta Della Vecchia
Nicoletta Della Vecchia
AVAlberto Villani
Alberto Villani
Background: Atraumatic limping is a frequent cause of consultation in Pediatric Emergency Departments (PED) and often represents a challenge for pediatricians for its variability in etiology ranging from benign causes to potential crippling conditions. The aims of this research are to illustrate the clinical features of acute limping children (LC) and to identify the possible red flags that could help to make a diagnosis of severe pathologies. Methods: We carried out a retrospective study about non-traumatic limping children referred to the PED of Bambino Gesù Children’s Hospital over a 2-year period. We divided the cohort into three groups based on the patient’s age: toddlers, children and adolescents. We considered crippling conditions: oncologic etiologies, bone or neurological infections, epiphysiolysis, Perthes disease, Guillain Barrè syndrome and non-accidental injuries. Results: We analyzed 485 patients. At clinical evaluation, 19.5% of the patients presented at least one sign and/or symptom of red flags. Crippling conditions (6.2% of the total population) showed red flags in 36.7%. Transient synovitis of the hip was the most frequent diagnosis. We found crippling conditions in 30 patients, mostly represented by toddlers. Conclusions: Our data suggest that toddlers and patients presenting red flags should be evaluated with particular suspicion because they have an increased risk of underlying severe conditions.

3 October 2025 in Annals of Hematology
Verified
Journal Article
Open access
PDF file
GCGabriele Canciani
Gabriele Canciani
ACAnna Cascone
Anna Cascone
AMAntonio Musolino
Antonio Musolino
ATAntonio Torelli
Antonio Torelli
EMEmanuela Monteferrario
Emanuela Monteferrario
GCGiulia Ceglie
Giulia Ceglie
Immune thrombocytopenia (ITP) in pediatrics is typically self-limiting, yet a subset develops refractory ITP (rITP), which persists despite standard first-line treatments. Clinical evidence on the efficacy of second-line therapies in this condition, such as mycophenolate mofetil (MMF), rituximab (RTX) and romiplostim, remains limited. This study aims to evaluate the efficacy of second-line therapies for the management of rITP in a cohort of 33 pediatric patients treated at Ospedale Pediatrico Bambino Gesù over a 16-year period. Some of these patients switched second-line therapies due to inadequate clinical responses, thus receiving more than one treatment over the study period. Collectively, patients in our cohort received MMF ( n = 20), RTX ( n = 16), romiplostim ( n = 15), dapsone ( n = 3) and sirolimus ( n = 2). Response rates were 50% (10/20) for mycophenolate mofetil (MMF), 18.8% (3/16) for rituximab, and 66.7% (10/15) for romiplostim. None of the 3 patients treated with dapsone showed clinical benefits. One of the two patient undergoing sirolimus achieved a sustained clinical response. Combination therapies showed promising results, particularly the association of MMF and romiplostim. Our results provide new insights into the management of pediatric rITP, while highlighting the need for further studies to establish evidence-based treatment guidelines and improve outcomes of this condition.

26 February 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
MAMarilena Agosta
Marilena Agosta
VCVenere Cortazzo
Venere Cortazzo
MOManuela Onori
Manuela Onori
BLBarbara Lucignano
Barbara Lucignano
GVGianluca Vrenna
Gianluca Vrenna
PBPaola Bernaschi
Paola Bernaschi
Background/Objectives: Paediatric osteoarticular infections (POAIs) present unique diagnostic and therapeutic challenges. Microbiological culture (MC) is typically time-consuming and lacks sensitivity, especially when patients have received antibiotics. The BIOFIRE® Joint Infection Panel (BJIP) is a syndromic molecular assay for the direct identification of most pathogens causing POAIs. Methods: We evaluated BJIP in 17 synovial fluids, and then, we retrospectively assessed its utility in 93 off-label specimens (i.e., 25 purulent fluids/biopsies and 68 whole blood samples). All specimens were collected from October 2022 to March 2024 from paediatric patients admitted at the Bambino Gesù Children’s Hospital in Rome. Results: A bacterial pathogen was isolated in only one of 17 synovial fluid cultures, while BJIP identified eight additional microorganisms in MC-negative cases. The most frequently detected pathogen was S. aureus (44.5%, 4/9). BJIP performance in synovial fluids showed an overall positive percentage agreement (PPA) and negative percentage agreement (NPA) of 100% and 88.1%, respectively, compared to MC. All positive results (n/N = 9/17) were considered medically significant, with an increase in NPA to 100%. In purulent fluids/biopsies, BJIP and MC were concordant in 72% of cases (n/N = 18/25), with a per-sample PPA and NPA of 90% and 60%, respectively. For whole blood samples, almost all samples were negative by both methods (i.e., reference blood culture and BJIP), and the molecular test did not enable any further microbiological diagnosis. Conclusions: The BIOFIRE® Joint Infection Panel rapidly and accurately enabled or excluded a diagnosis of a POAI (~1 vs. 24–96 h for MC), optimising antimicrobial therapy.

26 October 2023 in Children
Verified
Journal Article
Open access
PDF file
GGGiacomo Garone
Giacomo Garone
MRMarco Roversi
Marco Roversi
MPMara Pisani
Mara Pisani
FPFrancesco La Penna
Francesco La Penna
AMAntonio Musolino
Antonio Musolino
URUmberto Raucci
Umberto Raucci
Background: To date, no study has specifically examined children with acute-onset pupillary motility disorders (APMD). Especially in the Emergency Department (ED), it is crucial to distinguish benign and transient conditions from life-threatening or urgent conditions (UCs). The aim of the study is to describe the clinical characteristics of children with APMD and their association with an increased risk of UCs. Methods: We conducted a pediatric retrospective study of APMD referred to ED over a 10-year period. We described the characteristics in the overall sample and in two subgroups divided according to urgency of the underlying condition. Furthermore, we applied a logistic regression model to identify the variables predictive of LT condition. Results: We analyzed 101 patients. In 59.4%, the APMD was isolated. In patients with extra-ocular involvement, the most frequently associated features were altered consciousness, headache, and vomiting. Exposure to toxic agents was reported in 48.5%. Urgent conditions occurred significantly more frequently in older children, presenting bilateral APMD and/or other ocular or extra-ocular manifestations. Conclusions: Our study shows that UCs most commonly occur in patients presenting with bilateral APMD and other associated features. In unilateral/isolated APMD ophthalmological examination, exclusion of toxic exposure and observation until resolution of symptoms should be recommended.

7 August 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AMAntonio Musolino
Antonio Musolino
CPcarlo giovanni piacentini
carlo giovanni piacentini
GAGiovanni Antonelli
Giovanni Antonelli
LGLivia Gargiullo
Livia Gargiullo
FSFlavio Storelli
Flavio Storelli
AVAlberto Villani
Alberto Villani
Introduction: Kawasaki disease (KD) is an acute systemic vasculitis and the leading cause of acquired pediatric heart disease in high-income countries. Coronary artery aneurysms (CAA) represent the most severe complication and drive long-term cardiovascular risk. Despite improved outcomes with early intravenous immunoglobulin therapy, follow-up strategies remain heterogeneous, particularly for patients showing CAA regression. Dynamic risk stratification based on coronary Z-scores has been proposed, but long-term real-world data are still needed to optimize surveillance. Methods: We conducted a single-center, retrospective study including pediatric patients (age 1 month–18 years) with KD complicated by CAA, followed at Bambino Gesù Children’s Hospital (Rome) between 1999 and 2024. Coronary involvement was assessed using Boston Z-scores of the right coronary artery, left main coronary artery, and left anterior descending artery. CAA severity over time was analyzed using a composite MAX SCORE (highest Z-score among coronary branches) along with the 1-YEAR MAX SCORE (highest MAX SCORE reached within the 1 year of disease). The distribution and timing of cardiac computed tomography angiography (CCTA) and exercise stress testing (EST) during follow-up were analyzed in relation to coronary severity. Results: Among 502 KD patients, 122 (24.3%) developed CAA; 113 were included in the analysis. Mean age at diagnosis was 24.6 months (M/F 3.5:1). Multivessel involvement was observed in 72%, most frequently affecting the left anterior descending artery. Long-term follow-up ≥10 years was available for 31.9% of patients. Most changes in coronary severity occurred within the first year after disease onset, with complete CAA regression in 76.1% of patients. Conversely, 53% of patients affected by giant aneurysms at 12 months showed persistent severe disease at last follow-up. EST (164 tests in 40 patients) was almost universally negative for inducible ischemia (163/164), whereas CCTA (47 exams in 35 patients) was preferentially performed early and in higher-risk patients. Test prescription correlated more closely with 1-YEAR MAX SCORE than with contemporaneous severity. Echocardiography showed systematic differences compared with CCTA for right coronary and left anterior descending artery Z-scores. Discussion: In our experience, early coronary status was closely associated with the intensity of long-term surveillance strategies in KD. The 1-YEAR MAX SCORE was associated with subsequent patterns of coronary evolution, and the continuous 1-year Maximum Z-score showed good discriminatory ability for persistent CAA on ROC analysis, pending external validation. While the low rate of positive findings on EST raises questions about its diagnostic yield in real-world practice, CCTA provided detailed anatomical characterization. Overall, these findings suggest that early coronary severity may help inform individualized, severity-driven follow-up strategies, warranting confirmation in prospective multicenter studies.